#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal dystrophy Deafness bilateral Chronic myeloid leukaemia (in remission) Epilepsy with myoclonic-atonic seizures Hypotransferrinaemia Non-Hodgkin's lymphoma refractory Short-bowel syndrome Primary biliary cholangitis Fungal infection Urethral valves Chronic lymphocytic leukaemia refractory Acute on chronic liver failure Hypophosphatasia Neuroblastoma recurrent Infantile spasms More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Life with Disease Atypical teratoid/rhabdoid tumour of CNS Glycogen storage disease type II – Treatment Progressive multifocal leukoencephalopathy Indolent systemic mastocytosis – Diagnostics Propionic acidaemia Prolymphocytic leukaemia Nephroblastoma Chondrosarcoma metastatic – Trials in Disease Systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM HYDROXIDE Indometacin Ph. Eur. Isoniazid Valproate Semisodium Glofitamab Lumasiran Fosphenytoin Sodium Wt1 Lamp Mrna Dc Emedastine Cloxacillin Bi 765845 TRV045 Omp72 GOLD SODIUM THIOSULFATE Dorzolamide Hydrochloride Bexmarilimab Mk-0482 Haemophilus Influenzae Copanlisib Dihydrochloride Dornase Alfa More therapies…

    Learn about Your Condition

    Schizophreniform disorder Lymphangioleiomyomatosis Arthralgia Rett syndrome Cardiac ventricular thrombosis Naevus flammeus Haematological infection Invasive breast carcinoma Progressive multiple sclerosis Colon cancer stage II Bronchopulmonary aspergillosis Deafness bilateral Thromboangiitis obliterans Systemic candida Retinal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Magnetic resonance imaging
    • Neuropathy peripheral
    Investigated Drugs:
    • Gadoquatrane
    • Gadobutrol
    • Gadoteric Acid
    Bulgaria Czechia France Germany Hungary Italy +2

  • Study on the Effectiveness of Vidofludimus Calcium (IMU-838) in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Germany Lithuania Poland

  • Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    • Pain
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Bulgaria Czechia Germany Hungary Poland

  • Study on the Effects of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Cenerimod
    Bulgaria France Greece Poland Romania

  • Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary myelofibrosis
    • Myelofibrosis
    Investigated Drugs:
    • Danazol
    • Hydroxycarbamide
    • Pacritinib
    Bulgaria Czechia France Hungary Italy Poland +2

  • Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Austria Belgium Bulgaria Czechia France Greece +8

  • Study of TX000045 for Pulmonary Hypertension in Heart Failure Patients with Preserved Ejection Fraction

    Not recruiting

    2 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • TX000045
    Austria Belgium Bulgaria Germany Latvia Poland +3

  • Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Guselkumab
    Bulgaria Croatia Czechia Estonia Germany Greece +8

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7
Previous Page
1 … 18 19 20

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!